Cargando…
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38
Oxidative stress has been shown to play a crucial role in the pathophysiology of the neurodegenerative disease Ataxia Telangiectasia. We have recently demonstrated that Dexamethasone treatment is able to counteract the oxidative state by promoting nuclear factor erythroid 2-related factor 2 (NRF2) n...
Autores principales: | Biagiotti, Sara, Bianchi, Marzia, Rossi, Luigia, Chessa, Luciana, Magnani, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527213/ https://www.ncbi.nlm.nih.gov/pubmed/31107893 http://dx.doi.org/10.1371/journal.pone.0216668 |
Ejemplares similares
-
Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone
por: Menotta, Michele, et al.
Publicado: (2018) -
Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
por: Leuzzi, Vincenzo, et al.
Publicado: (2015) -
Ataxia-telangiectasia: A new remitting form with a peculiar transcriptome signature
por: Leuzzi, Vincenzo, et al.
Publicado: (2018) -
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T
por: Menotta, Michele, et al.
Publicado: (2017) -
Cutaneous granulomatosis and combined immunodeficiency revealing Ataxia-Telangiectasia: a case report
por: Folgori, Laura, et al.
Publicado: (2010)